Benign prostatic hyperplasia
Conditions
Interventions
Group A :Transurethral holmium laser enucleation of prostate
Group B :Transurethral Nd: YAG laser enucleation of prostate
Group C :Transurethral plasma bipolar prostatectomy
Sponsors
Renmin Hospital of Wuhan University
Eligibility
Sex/Gender
Male
Age
55 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. The patients had clinical symptoms such as urgency of urination, increased nocturia and dysuria; 2. The examination of the digital rectum showed that the prostate became larger and stronger, and the central sulcus became shallow or disappeared; 3. Urinary tract obstruction under urodynamics; 4. IPSS > 10; 5. The subjects had no mental illness or language dysfunction, could understand the situation of this study and had signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with previous history of prostate cancer or positive results of prostate puncture; 2. Previous urethral injury and stricture; 3. The patients with lower urinary tract injury caused by previous urethra or transurethral operation, etc; 4. Taking anticoagulants such as aspirin, warfarin, dabigatran, rivasaban, apixaban, etc. for more than one week without stopping; 5. Blood system diseases and abnormal coagulation; 6. Combined with serious systemic diseases, heart disease, pulmonary insufficiency and important organ failure, it can not tolerate anesthesia or operation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score; Quality of life score;Maximum urine flow rate (Qmax);residual urine volume (PVR); | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation time;Bladder flushing time;Time with catheter;Prostate quality;hemoglobin; | — |
Countries
China
Contacts
Public ContactLi Haoyong
Renmin Hospital of Wuhan University
Outcome results
None listed